Abstract
Endocardial endothelial cells constitute a barrier between the circulating blood and ventricular cardiomyocytes. Although recently our group demonstrated the importance of this type of endothelial cells in excitation-secretion coupling, there is no information on whether this type of cells contributes to cardiac pathologies such as cardiac hypertrophy. Using the well-known model of human hypertrophy and heart failure, the UM-X7.1 hereditary cardiomyopathic hamster, our results showed that during the phase of necrosis and in the absence of cardiac hypertrophy, isolated endocardial endothelial cells underwent a significant increase in cell volume compared to cells isolated from age-matched normal hamsters. This increase of the volume of endocardial endothelial cells persisted during the development of cardiac hypertrophy in the hereditary cardiomyopathic hamster. These results demonstrate for the first time, that endocardial endothelial hypertrophy precedes the development of hypertrophy in hereditary cardiomyopathy and may, via its released factors, contribute to the development of cardiac hypertrophy. These results demonstrate the importance of endocardial endothelial cells in cardiac diseases such as hypertrophy. This type of cells constitutes a new target for understanding hypertrophy and heart failure.
References
Sun J, Deng H, Zhou Z, Xiong X, Gao L (2018) Endothelium as a potential target for treatment of abdominal aortic aneurysm. Oxid Med Cell Longev 2018: Article ID 6306542
Gravina AG, Dallio M, Masarone M, Rosato V, Aglitti A, Persico M, Loguercio C, Federico A (2018) Vascular endothelial dysfunction in inflammatory bowel diseases: pharmacological and nonpharmacological targets. Oxid Med Cell Longev 2018: Article ID 2568569
Knapp M, Tu X, Wu R (2018) Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. Acta Pharmacol Sin. [Epub ahead of print]
Ungvari Z, Tarantini S, Kiss T, Wren JD, Giles CB, Griffin CT, Murfee WL, Pacher P, Csiszar A (2018) Endothelial dysfunction and angiogenesis impairment in the ageing vasculature. Nat Rev Cardiol. [Epub ahead of print]
D’Orléans-Juste P, Houde M, Rae GA, Bkaily G, Carrier E, Simard E (2008) Endothelin-1 (1–31): from chymase-dependent synthesis to cardiovascular pathologies. Vascul Pharmacol 49:51–62
Jacques D, D’Orléans-Juste P, Magder S, Bkaily G (2017) Neuropeptide Y and its receptors in ventricular endocardial endothelial cells. Can J Physiol Pharmacol 95:1224–1229
Jacques D, Abdel-Samad D (2007) Neuropeptide Y (NPY) and NPY receptors in the cardiovascular system: implication in the regulation of intracellular calcium. Can J Physiol Pharmacol 85:43–53
Jacques D, Sader S, Perreault C, Abdel-Samad D, Provost C (2006) Roles of nuclear NPY and NPY receptors in the regulation of the endocardial endothelium and heart function. Can J Physiol Pharmacol 84:695–705
Jacques D, Sader S, Perreault C, Abdel-Samad D, Jules F, Provost C (2006) NPY, ET-1, and Ang II nuclear receptors in human endocardial endothelial cells. Can J Physiol Pharmacol 84:299–307
Jacques D, Sader S, Perreault C, Abdel-Samad D (2006) NPY and NPY receptors: presence, distribution and roles in the regulation of the endocardial endothelium and cardiac function. EXS 95:77–87
Brutsaert DL (2003) Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 831:59–115
Bkaily G, Jacques D (2017) Na+–H+ exchanger and proton channel in heart failure associated with Becker and Duchenne muscular dystrophies. Can J Physiol Pharmacol 95:1213–1223
Bkaily G, Chahine M, Al-Khoury J, Avedanian L, Beier N, Scholz W, Jacques D (2015) Na(+)-H(+) exchanger inhibitor prevents early death in hereditary cardiomyopathy. Can J Physiol Pharmacol 93:923–934
Chahine M, Bkaily G, Nader M, Al-Khoury J, Jacques D, Beier N, Scholz W (2005) NHE-1-dependent intracellular sodium overload in hypertrophic hereditary cardiomyopathy: prevention by NHE-1 inhibitor. J Mol Cell Cardiol 38:571–582
Jacques D, Abdel-Karim Abdel-Malak N, Abou Abdallah N, Al-Khoury J, Bkaily G (2017) Difference in the response to angiotensin II between left and right ventricular endocardial endothelial cells. Can J Physiol Pharmacol 95:1271–1282
Jacques D, Abdel Malak NA, Sader S, Perreault C (2003) Angiotensin II and its receptors in human endocardial endothelial cells: role in modulating intracellular calcium. Can J Physiol Pharmacol 81:259–266
Abdel-Samad D, Perreault C, Ahmarani L, Avedanian L, Bkaily G, Magder S, D’Orléans-Juste P, Jacques D (2012) Differences in neuropeptide Y-induced secretion of endothelin-1 in left and right human endocardial endothelial cells. Neuropeptides 46:373–382
Bkaily G, Al-Khoury J, Simon Y, Jacques D (2017) Intracellular free calcium measurement using confocal imaging. Methods Mol Biol 1527:177–187
Bkaily G, Pothier P, D’Orléans-Juste P, Simaan M, Jacques D, Jaalouk D, Belzile F, Hassan G, Boutin C, Haddad G, Neugebauer W (1997) The use of confocal microscopy in the investigation of cell structure and function in the heart, vascular endothelium and smooth muscle cells. Mol Cell Biochem 172:171–194
Bkaily G, Jacques D, Pothier P (1999) Use of confocal microscopy to investigate cell structure and function. Methods Enzymol 307:119–135
Smiljic S (2017) The clinical significance of endocardial endothelial dysfunction. Medicina (Kaunas) 53:295–302
Gerdes AM, Liu Z, Zimmer HG (1994) Changes in nuclear size of cardiac myocytes during the development and progression of hypertrophy in rats. Cardioscience 5:203–208
Koda M, Takemura G, Okada H, Kanoh M, Maruyama R, Esaki M, Li Y, Miyata S, Kanamori H, Li L, Ogino A, Kondo T, Minatoguchi S, Fujiwara T, Fujiwara H (2006) Nuclear hypertrophy reflects increased biosynthetic activities in myocytes of human hypertrophic hearts. Circ J 70:710–718
Schoner A, Tyrrell C, Wu M, Gelow JM, Hayes AA, Lindner JR, Thornburg KL, Hasan W (2015) Endocardial endothelial dysfunction progressively disrupts initially anti then pro-thrombotic pathways in heart failure mice. PLoS ONE 10:e0142940
Honoré JC, Carrier E, Fecteau MH, Tirapelli CR, Bkaily G, D’Orleans-Juste P (2008) Nonselective ETA/ETB-receptor blockade increases systemic blood pressure of Bio 14.6 cardiomyopathic hamsters. Can J Physiol Pharmacol 86:394–401
Nakamura F, Nagano M, Kobayashi R, Higaki J, Mikami H, Kawaguchi N, Onishi S, Ogihara T (1994) Chronic administration of angiotensin II receptor antagonist, TCV-116, in cardiomyopathic hamsters. Am J Physiol 267:H2297–H2304
Ljubojevic S, Radulovic S, Leitinger G, Sedej S, Sacherer M, Holzer M, Winkler C, Pritz E, Mittler T, Schmidt A, Sereinigg M, Wakula P, Zissimopoulos S, Bisping E, Post H, Marsche G, Bossuyt J, Bers DM, Kockskämper J, Pieske B (2014) Early remodeling of perinuclear Ca2+ stores and nucleoplasmic Ca2+ signaling during the development of hypertrophy and heart failure. Circulation 130:244–255
Jacques D, Bkaily G, Jasmin G, Ménard D, Proschek L (1997) Early fetal like slow Na+ current in heart cells of cardiomyopathic hamster. Mol Cell Biochem 176:249–256
Acknowledgements
This work was supported by grants from NSERC (Grant No. RGPIN-2017-05508) and the Canadian Institutes of Health Research (CIHR) (Grant No. MOP-119398).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Jacques, D., Bkaily, G. Endocardial endothelial cell hypertrophy takes place during the development of hereditary cardiomyopathy. Mol Cell Biochem 453, 157–161 (2019). https://doi.org/10.1007/s11010-018-3440-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-018-3440-7